We are live on
!
Find out more
CC
Clearline Capital Portfolio holdings
AUM
$1.93B
1-Year Est. Return
38.13%
This Fund
S&P 500
This Quarter
Est. Return
+18.02%
1 Year Est. Return
+38.13%
3 Year Est. Return
+17.96%
5 Year Est. Return
-8.68%
10 Year Est. Return
-18.93%
AUM
$233M
AUM Growth
+$13.5M
(+6.1%)
Cap. Flow
-$17.7M
Cap. Flow
% of AUM
-7.58%
Top 10 Holdings %
Top 10 Hldgs %
50.02%
Holding
78
New
26
Increased
11
Reduced
17
Closed
23
Top Buys
| 1 |
Altria Group
MO
|
+$8.91M |
| 2 |
Fluor
FLR
|
+$8.14M |
| 3 |
Advance Auto Parts
AAP
|
+$5.41M |
| 4 |
Virgin Galactic
SPCE
|
+$5.24M |
| 5 |
Boeing
BA
|
+$4.92M |
Top Sells
| 1 |
FLXN
Flexion Therapeutics, Inc.
FLXN
|
+$10.9M |
| 2 |
Cars.com
CARS
|
+$9.55M |
| 3 |
DXC Technology
DXC
|
+$8.44M |
| 4 |
Medifast
MED
|
+$6.53M |
| 5 |
CBLK
Carbon Black, Inc. Common Stock
CBLK
|
+$5.71M |
Sector Composition
| 1 | Technology | 38.69% |
| 2 | Industrials | 21.2% |
| 3 | Communication Services | 15.69% |
| 4 | Consumer Staples | 7.38% |
| 5 | Consumer Discretionary | 6.02% |
Similar funds
DCM
IHL
HC
RCAG
AF
QOP
HCL
6CM
Clearline Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Clearline Capital held 78 positions worth $233M, up 6.1% from $219M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Clearline Capital withdrew a net $17.7M in Q4 2019, closing 23 positions and reducing 17 holdings. Its most notable exit was Flexion Therapeutics, Inc., an estimated $10.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 43% a quarter earlier, followed by Industrials and Communication Services.
Against the trend, Clearline Capital opened a new position in Altria Group worth $9.43M.
- Clearline Capital's largest Q4 2019 buy was Altria Group: 189,000 shares worth $9.43M.
- Clearline Capital added most to Paramount Global Class B in Q4 2019, an estimated $4.26M increase.
- Clearline Capital's biggest Q4 2019 reduction was Cars.com, cutting an estimated $9.55M.
- Clearline Capital fully exited Flexion Therapeutics, Inc. in Q4 2019, selling an estimated $10.9M.
- Clearline Capital's ten largest holdings make up 50% of its $233M portfolio in Q4 2019.
- Clearline Capital opened 26 new positions and closed 23 in Q4 2019.
- Clearline Capital's portfolio value rose 6.1% quarter-over-quarter to $233M.
Based on Clearline Capital's 13F filing for Q4 2019, filed 14 Feb 2020.